Why Backtest Results Lie — and How to Make Them Honest

Backtesting is the foundational tool of quantitative strategy development, yet the vast majority of backtests in production today are statistically meaningless. The problem is not the software — modern backtesting engines are technically competent — it is the methodology. Three systematic biases conspire to make backtests look far more profitable than the strategies they represent.

First, overfitting. When a researcher tests hundreds of parameter combinations and selects the one with the highest Sharpe ratio, the selected backtest reflects random noise as much as genuine signal. The probability of finding a parameter set that looks profitable by chance increases dramatically with the number of trials, and most backtesting workflows do not adjust for this multiple-testing problem.

Second, survivorship bias. If your backtest universe includes only companies that exist today, you are implicitly assuming perfect foresight about which companies survived. Strategies that appear to buy "quality" stocks are often just buying survivors, and their apparent alpha disappears when delisted securities are included.

Third, look-ahead bias. Subtle forms of data leakage — using adjusted prices before the adjustment date, incorporating economic data before its official release, or filtering the universe based on future information — can inflate backtest returns by 200-500 basis points per year.

At UTexas, our research platform enforces guardrails against all three biases by default. Multiple-hypothesis correction (Bonferroni or Holm-Bonferroni) is applied automatically when a researcher runs more than one backtest in a session. Point-in-time datasets reconstruct the information set that was actually available on each historical date. And a walk-forward validation framework splits data into non-overlapping train, validate, and test periods with a mandatory embargo gap. The result is backtests that are less flattering but far more predictive of live performance.